Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Erectile dysfunction in heart disease patients.

I Sainz1, J Amaya, M Garcia

  • 1Cardiology Department, Cardiac Rehabilitation Center, Hospital de Valme, Seville, Spain. ignacio.sainz.sspa@juntadeandalucia.es

International Journal of Impotence Research
|October 22, 2004
PubMed
Summary

Erectile dysfunction (ED) is common in heart disease patients due to atherosclerosis and medications. Sexual activity is generally safe for patients who can complete two stages of the Bruce protocol, with sildenafil often a suitable treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

<sup>18</sup>F-DOPA PET/CT: Diagnosis of a synchronous appendiceal neuroendocrine tumor in a patient with Medullary Thyroid Cancer.

Revista espanola de medicina nuclear e imagen molecular·2023
Same author

[Experimental cadaveric study assesing protection and osteotomy guide system (BARU) in hallux valgus surgery using Reverdin-Isham technic].

Acta ortopedica mexicana·2021
Same author

Influence of volumetric loading rate on aerobic sewage treatment for indigenous algal growth.

Water science and technology : a journal of the International Association on Water Pollution Research·2019
Same author

Difference of train-of-four fade induced by nondepolarizing neuromuscular blocking drugs: a theoretical consideration on the underlying mechanisms.

Journal of anesthesia·2013
Same author

[Diagnostic value of Gram staining of peri-catheter skin and the connection in the prediction of intravascular-catheter-related bacteremia].

Enfermedades infecciosas y microbiologia clinica·1998
Same author

[Rendu-Osler-Weber disease. Nontraumatic hemothorax and pulmonary sarcoidosis].

Revista clinica espanola·1998

Area of Science:

  • Cardiology
  • Urology
  • Sexual Medicine

Background:

  • Atherosclerosis affects both coronary and penile arteries, contributing to erectile dysfunction (ED) in heart disease patients.
  • ED in these patients is multifactorial, involving organic, psychological, and pharmacological causes, including medications for cardiovascular conditions.
  • The incidence of ED post-myocardial infarction is significant, ranging from 38% to 78%.

Purpose of the Study:

  • To assess the cardiovascular risk associated with sexual activity in heart disease patients.
  • To establish guidelines for managing erectile dysfunction in patients with cardiovascular disease.
  • To determine appropriate treatment strategies for ED in this population.

Main Methods:

  • Evaluation of cardiovascular risk through medical history, echocardiography, and stress testing (Bruce protocol).

Related Experiment Videos

  • Assessment of energy expenditure during sexual intercourse (3.7-5 METs).
  • Review of contraindications and recommendations for oral ED treatments.

    • Main Results:

    • Sexual intercourse requires moderate energy expenditure (up to 5 METs), generally considered safe for patients with a functional capacity exceeding 7 METs (achieved by completing two stages of the Bruce protocol).
    • Sildenafil is recommended as a first-line oral therapy for ED in heart disease patients when sexual activity is not contraindicated.
    • Specific contraindications and treatment recommendations are discussed.

    Conclusions:

    • Sexual activity can be safely undertaken by many heart disease patients with ED, provided cardiovascular risk is assessed.
    • Oral sildenafil is a viable and effective treatment option for ED in stable heart disease patients.
    • A comprehensive approach integrating cardiovascular assessment and appropriate ED pharmacotherapy is crucial.